Medical University of Vienna
Vienna, 1090, Austria
NCT Number: NCT03012867
Different enteral nutrition formulas are tested on their effect on glucose homeostasis in critically ill medical patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Vienna, 1090, Austria
To assess whether enteral nutrition fomulas based either on fat or glucose influence glucose homeostasis differently in critically ill medical patients. All patients are admitted to a tertiary ICU and require mechanical ventilation.
Resting energy expenditure is assessed at baseline in the fasting state by indirect calorimetry. Total energy demand is calculated and patients are randomized to receive fat-based or glucose-based nutrition which is administered continously for 7 days. Indirect calorimetry is repeated on days 3 and 7 under continous nutrition. During the study period, various parameters of glucose homeostasis are assessed. Daily, there will be at least 3 measurements of blood glucose, more if the treating physician deems it necessary. Daily average glucose, daily glucose variability, overall area under the curve for glucose are calculated. Furthermore, energy intake by nutrition, medications (i.e. propofol), and glucose infusion, as well as substrate intake, and insulin demand per 24hrs are determined daily. Adverse effects such as episodes of hyper- or hypoglycemia, cholestasis, hypertriglyceridemia, diarrhea, vomiting, and the amount of gastric residual volume are noted.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients receive Diben continously for 7 days
Patients receive Fresubin original fibre continously for 7 days
Time frame: up to 7 days
Time frame: up to 7 days
Time frame: up to 7 days
Time frame: 7 days
Medical University of Vienna
Other
Effect of Different Enteral Nutrition Formulas on Glucose Homeostasis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05561517
Autoimmune Diseases, Diabetes Mellitus
Aarhus, Region Midt, Denmark
View Trial DetailsNCT04266015
Atrophy, Behavior
Yanchao, Kaohsiung, Taiwan
View Trial DetailsNCT04058015
Abdominal Injuries, Abdominal Injury
Kaohsiung City, Taiwan
View Trial DetailsNCT03094533
Hyperglycemia Stress, Pathologic Processes
Daegu, South Korea
View Trial Details